Cargando…
Evaluation of E148Q and Concomitant AA Amyloidosis in Patients with Familial Mediterranean Fever
The aim of the study was to compare the clinical phenotype of patients with familial Mediterranean fever (FMF)-related AA amyloidosis, according to the age of FMF diagnosis and E148Q genotype. Patients with biopsy-confirmed FMF-related AA amyloidosis were included in the study. Tel-Hashomer criteria...
Autores principales: | Arici, Zehra Serap, Romano, Micol, Piskin, David, Guzel, Ferhat, Sahin, Sezgin, Berard, Roberta A., Yilmaz, Mahmut I., Demirkaya, Erkan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397076/ https://www.ncbi.nlm.nih.gov/pubmed/34441808 http://dx.doi.org/10.3390/jcm10163511 |
Ejemplares similares
-
Assessment of Surrogate Markers for Cardiovascular Disease in Familial Mediterranean Fever-Related Amyloidosis Patients Homozygous for M694V Mutation in MEFV Gene
por: Sahin, Sezgin, et al.
Publicado: (2022) -
Cardiovascular disease risk assessment in patients with familial Mediterranean fever related renal amyloidosis
por: Romano, Micol, et al.
Publicado: (2020) -
Current State of Precision Medicine in Primary Systemic Vasculitides
por: Demirkaya, Erkan, et al.
Publicado: (2019) -
Number of Episodes Can Be Used as a Disease Activity Measure in Familial Mediterranean Fever
por: Piskin, David, et al.
Publicado: (2022) -
Anti-Inflammatory, Antioxidant, and Anti-Atherosclerotic Effects of Natural Supplements on Patients with FMF-Related AA Amyloidosis: A Non-Randomized 24-Week Open-Label Interventional Study
por: Romano, Micol, et al.
Publicado: (2022)